BioXcel Therapeutics (BTAI) EPS (Basic) (2017 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly EPS (Basic) of -$0.6 for Q1 2026, up 78.9% year-over-year from -$0.34 in Q1 2025, and down 4.2% quarter-over-quarter from -$0.58 in Q4 2025.
BioXcel Therapeutics (BTAI) EPS (Basic) (2017 - 2026) Analysis & Trends
BioXcel Therapeutics' EPS (Basic) history runs 10 years deep, the most recent figure standing at -$0.6 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 78.9% year-over-year to -$0.6; the TTM figure through Mar 2026 stood at -$2.5 (up 79.77% YoY), while the FY2025 annual figure was -$5.44, up 94.63% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.6, down from -$0.58 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.58 in Q4 2025, with the low at -$96.97 in Q4 2022.
- The 5-year median for EPS (Basic) is -$11.53 (2023), against an average of -$21.81.
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) slumped 511.79% in 2022, then surged 88.11% in 2023.
- BioXcel Therapeutics' EPS (Basic) stood at -$96.97 in 2022, then soared by 88.11% to -$11.53 in 2023, then surged by 75.23% to -$2.86 in 2024, then soared by 79.75% to -$0.58 in 2025, then fell by 4.2% to -$0.6 in 2026.
- Business Quant data shows BTAI's EPS (Basic) at -$0.6 in Q1 2026, -$0.58 in Q4 2025, and -$1.26 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 7.82 |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 1.43 |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | BioXcel Therapeutics | 24.95 Mn | 24.95 Mn | 160,000.00 | -0.47 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.47 |
| Mar 31, 2026 | -0.60 |
| Dec 31, 2025 | -0.58 |
| Sep 30, 2025 | -1.26 |
| Jun 30, 2025 | -2.53 |
| Mar 31, 2025 | -2.86 |
| Dec 31, 2024 | -2.86 |
| Sep 30, 2024 | -6.97 |
| Jun 30, 2024 | -8.08 |
| Mar 31, 2024 | -13.90 |
| Dec 31, 2023 | -11.53 |
| Sep 30, 2023 | -29.82 |
| Jun 30, 2023 | -32.90 |
| Mar 31, 2023 | -47.67 |
| Dec 31, 2022 | -96.97 |
| Sep 30, 2022 | -33.42 |
| Jun 30, 2022 | -34.16 |
| Mar 31, 2022 | -44.69 |
| Dec 31, 2021 | -15.85 |
| Sep 30, 2021 | -53.42 |